This is a report from the Deloitte Center for Government Insights that describes a ecological approach to addressing the opioid crisis. A portfolio of policies, multi-sector collaboration, innovation, and feasibility/sustainability are features of this approach. 

This is a report from the Illinois Public Health Institute that conducted interviews with key informants in eight states with robust emergency department (ED) naloxone distribution programs to provide recommendations that inform payment and financing of ED-based naloxone distribution.

This is a mapping website from the Harm Reduction Coalition that allows users to search for access to naloxone and syringe service programs. 

This is the website of the Foundation of Opioid Response Efforts (FORE), a national, private, grantmaking foundation that funds innovative responses to the opioid crisis and disseminates evidence-based best practices through webinars that feature a panel of experts. 

This website provides webinars, journal articles, and reports to support a community's response to the opioid crisis during the coronavirus pandemic. The webinars feature a panel of experts in the field and include a recording and presentation slides. 

This is a manual created by the Harm Reduction Coalition that is designed to outline the process of developing and managing an Overdose Prevention and Education Program (OPEP), with or without a take-home naloxone component. It offers practical suggestions and considerations rooted in harm reduction - an approach to drug use that promotes and honors the competence of drug users to protect themselves, their loved ones, and their communities and the belief that drug users have a right to respect, health, and access to life-saving tools and information. There are several case studies of existing harm reduction program models. 

This is a report from the World Health Organization (WHO) and other collaborating organizations that is designed to assist in responding to HIV among injecting drug users globally by expanding syringe service programs (SSP). How to start a new SSP, scale up existing SSP, and vital settings where SSP should be present are discussed. 

The Harm Reduction Coalition is an organization that challenges the persistent stigma faced by people who use drugs and advocates for policy and public health reform. Their website contains many harm reduction-oriented resources. 

This website from the Harm Reduction Coalition gives general information about the coronavirus, guidance for people who use drugs during the pandemic, and information on safer drug use during the COVID-19 outbreak. 

This is a report from NASHP that discusses how states are providing guidance to ensure access to harm reduction services and highlights programs that have successfully adapted to the coronavirus pandemic. 

This is an interactive toolkit from the College of Psychiatric and Neurologic Pharmacists that provides guidelines and strategies on the consequences of injection drug use, harm reduction services, stigma, and professional and policy support. There are many links to resources, references, and data sources.

This is an issue brief from several collaborating agencies that offers statistics on opioid misuse and overdose deaths in rural Appalachian communities. Strategies and resources to address opioid issues are highlighted within this document. In addition, the brief covers recommendations to assist policymakers, funders, and leaders working to reduce opioid-related health disparities.